{"organizations": [], "uuid": "3e5c0d8745ea8da3770a11c15fc811101a1debc4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-mylan-acquires-global-development/brief-mylan-acquires-global-development-marketing-rights-for-meloxicam-idUSFWN1RO0SJ", "country": "US", "domain_rank": 408, "title": "BRIEF-Mylan Acquires Global Development & Marketing Rights For Meloxicam", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-11T19:41:00.000+03:00", "replies_count": 0, "uuid": "3e5c0d8745ea8da3770a11c15fc811101a1debc4"}, "author": "", "url": "https://www.reuters.com/article/brief-mylan-acquires-global-development/brief-mylan-acquires-global-development-marketing-rights-for-meloxicam-idUSFWN1RO0SJ", "ord_in_thread": 0, "title": "BRIEF-Mylan Acquires Global Development & Marketing Rights For Meloxicam", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "brief-mylan acquires global development & marketin", "sentiment": "negative"}, {"name": "brief-mylan acquires global development & marketing rights for meloxicam", "sentiment": "negative"}, {"name": "rights for meloxicam reuters staff", "sentiment": "none"}, {"name": "mylan nv", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "mylan", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 11, 2018 / 4:42 PM / Updated 23 minutes ago BRIEF-Mylan Acquires Global Development & Marketing Rights For Meloxicam Reuters Staff 1 Min Read \nApril 11 (Reuters) - Mylan NV: \n* MYLAN - ACQUIRED GLOBAL DEVELOPMENT & MARKETING RIGHTS FROM PRAYOG LABS TO BRING TO MARKET FAST-ACTING MELOXICAM AS PROPOSED NON-NARCOTIC ANALGESIC \n* MYLAN SAYS WILL BE SUBMITTING AN INVESTIGATIONAL NEW DRUG APPLICATION TO U.S. FDA FOR MELOXICAM Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-11T19:41:00.000+03:00", "crawled": "2018-04-11T20:10:48.004+03:00", "highlightTitle": ""}